troglitazone has been researched along with taurochenodeoxycholic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
| Chayama, K; Hyogo, H; Kanno, K; Nonaka, M; Tazuma, S | 1 |
2 other study(ies) available for troglitazone and taurochenodeoxycholic acid
| Article | Year |
|---|---|
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
Cytoprotective effect of tauroursodeoxycholate on hepatocyte apoptosis induced by peroxisome proliferator-activated receptor gamma ligand.
Topics: Apoptosis; Butadienes; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromans; Cytoprotection; Glycochenodeoxycholic Acid; Hepatocytes; Humans; JNK Mitogen-Activated Protein Kinases; Ligands; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitriles; p38 Mitogen-Activated Protein Kinases; Phosphorylation; PPAR gamma; Protein Kinase Inhibitors; Taurochenodeoxycholic Acid; Thiazolidinediones; Time Factors; Troglitazone | 2008 |